Zeria Pharmaceutical Co., Ltd. (4559) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Zeria Pharmaceutical Co., Ltd. (4559) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Zeria Pharmaceutical Co., Ltd. (4559) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Zeria Pharmaceutical Co., Ltd. (4559) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
36 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Zeria Pharmaceutical Co., Ltd. (Zeria), formerly Zeria Yakusho Kenkyusho Co., Ltd. is a pharmaceutical company that manufactures, sells, imports and exports pharmaceuticals and non-pharmaceutical products, veterinary pharmaceuticals, industrial chemicals and reagents, and other products. The company also offers ethical and OTC drugs and products. Its ethical products include therapeutic agent for functional dyspepsia, therapeutic agent for ulcerative colitis, therapeutic agent for gastritis and ulcers, proton pump inhibitor, therapeutic agent for hypophosphatemia, and others.

Zeria Pharmaceutical Co., Ltd. (4559) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of eac

  
Source:
Document ID
GDPH34362D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Zeria Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Zeria Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Zeria Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Zeria Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Zeria Pharmaceutical Co., Ltd., Medical Devices Deals, 2010 to YTD 201691
Zeria Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
Zeria Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deal Details1220
  Asset Purchase121
    Tillotts Pharma Acquires Entocort from AstraZeneca121
  Venture Financing131
    Cancer Prevention Pharma Raises US$0.4 Million In Venture Financing131
    Cancer Prevention Pharma Raises Funds Through Venture Financing141
    Cancer Prevention Pharma Secures US$0.55 Million In Venture Financing151
  Partnerships161
    Solid Form Solutions Enters Into Co-Promotion Agreement With Tillotts Pharma161
    Cambrex Enters Into Co-Development Agreement With Tillotts Pharma171
    Cancer Prevention Pharma Partners with SWOG181
  Licensing Agreements191
    Sucampo Pharma Enters into Option Agreement with Cancer Prevention Pharma191
    Tillotts Pharma Enters into Licensing Agreement with Numab201
    Eisai Enters into Licensing Agreement with Zeria Pharma for Proton Pump Inhibitor211
    Tillotts Pharma Amends Licensing Agreement with Cancer Prevention Pharma222
    Vifor Pharma Enters Into Licensing Agreement With Zeria Pharma For Ferinject242
    Tillotts Pharma Enters Into Licensing Agreement With The School of Pharmacy261
  Equity Offering271
    Cancer Prevention Pharma to Raise up to USD27 Million in IPO272
  Debt Offering291
    Cancer Prevention Pharma Raises USD2.3 Million in Private Placement of Notes Due 2018291
  Acquisition301
    Zeria Pharma Acquires Remaining 15% Stake In ZPD From Rorvig301
    Zeria Pharma Acquires Biofac311
Zeria Pharmaceutical Co., Ltd. - Key Competitors321
Key Employees331
Locations And Subsidiaries342
  Head Office341
  Other Locations &Subsidiaries342
Appendix361
  Methodology361
  About GlobalData361
  Contact Us361
  Disclaimer361

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Zeria Pharmaceutical Co., Ltd. (4559) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Zeria-Pharmaceutical-Co-Ltd-4559-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7857>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Zeria Pharmaceutical Co., Ltd. (4559) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Zeria-Pharmaceutical-Co-Ltd-4559-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7857>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research